{"DataElement":{"publicId":"2180958","version":"1","preferredName":"Glucksberg Gastrointestinal Graft Versus Host Disease Stage","preferredDefinition":"Numreic value to describe the extent of acute GVHD in the gastrointestinal system, using Glucksberg criteria. [Manually-curated]","longName":"GLUCK_GI_AGVHD_STG","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"2180956","version":"1","preferredName":"Glucksberg Gastrointestinal Graft Versus Host Disease","preferredDefinition":"Relating to the Glucksberg criteria for the assessment of acute GVHD in the Gastrointestinal tract.","longName":"GLUCK_GI_GVHD","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2660567","version":"1","preferredName":"Glucksberg Scale Gastrointestinal","preferredDefinition":"The Glucksberg scale is a severity index for grading acute graft-versus-host disease (GVHD) after allogeneic marrow transplantation. This index is based on the results of an analysis in which distinct patterns in the peak severity of GVHD involvement in the skin, liver, and gut were correlated with the risks of transplant-related mortality (TRM) and treatment failure (defined as relapse or death).:(GAS-tro-in-TES-tih-nul) GI.  Refers to the stomach and intestines.","longName":"C42297:C0521362","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glucksberg Scale","conceptCode":"C42297","definition":"The Glucksberg scale is a severity index for grading acute graft-versus-host disease (GVHD) after allogeneic marrow transplantation. This index is based on the results of an analysis in which distinct patterns in the peak severity of GVHD involvement in the skin, liver, and gut were correlated with the risks of transplant-related mortality (TRM) and treatment failure (defined as relapse or death).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gastrointestinal","conceptCode":"C0521362","definition":"(GAS-tro-in-TES-tih-nul) GI.  Refers to the stomach and intestines.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33E5C497-F55B-4C81-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-27","modifiedBy":"ONEDATA","dateModified":"2007-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2180944","version":"1","preferredName":"Graft Versus Host Disease","preferredDefinition":"Graft-versus-host disease. A reaction of donated bone marrow or peripheral stem cells against a person's tissue.","longName":"Graft Versus Host Disease","context":"CCR","contextVersion":"1","Concepts":[{"longName":"Graft Versus Host Disease","conceptCode":"C0018133","definition":"Graft-versus-host disease. A reaction of donated bone marrow or peripheral stem cells against a person's tissue.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2F0AC9A-50D9-3D8A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-02-12","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2F0AC9A-5112-3D8A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-12","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-02-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2768290","version":"1","preferredName":"Glucksberg Scale Gastrointestinal Stage","preferredDefinition":"An enumerated set of values using Glucksberg Diagnostic Criteria to evaluate and stage acute GVHD._The Glucksberg scale is a severity index for grading acute graft-versus-host disease (GVHD) after allogeneic marrow transplantation. This index is based on the results of an analysis in which distinct patterns in the peak severity of GVHD involvement in the skin, liver, and gut were correlated with the risks of transplant-related mortality (TRM) and treatment failure (defined as relapse or death)._A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body._1. An organ and the enveloping membrane of the body; includes, in addition to the epidermis and dermis, all of the derivatives of the epidermis, e.g., hairs, nails, sudoriferous and sebaceous glands, and mammary glands. Subdivisions of the skin surround various body parts; as a whole, the skin constitutes the external surface of the body. 2. The rind, capsule, or covering of any body or part._Pertaining to the stomach and intestines.","longName":"GLUCK_AGVHD_GI_STG","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":"Stage 1: Diarrhea 500-1000 mL or persistent nausea","ValueMeaning":{"publicId":"2768291","version":"1","preferredName":"Stage 1: Diarrhea 500-1000 mL or persistent nausea","longName":"2768291","preferredDefinition":"Stage 1: Diarrhea 500-1000 mL or persistent diarrhea in acute GVHD","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"52A62BCD-3B99-610A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"52A62BCD-3BB2-610A-E044-0003BA3F9857","beginDate":"2004-02-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-22","modifiedBy":"REEVESD","dateModified":"2008-07-22","deletedIndicator":"No"},{"value":"2","valueDescription":"Stage 2: Diarrheav1000-1500 mL","ValueMeaning":{"publicId":"2768292","version":"1","preferredName":"Stage 2: Diarrheav1000-1500 mL","longName":"2768292","preferredDefinition":"Stage 2: Diarrhea 1000-1500 mL in acute GVHD","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"52A62BCD-3BBE-610A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"52A62BCD-3BD7-610A-E044-0003BA3F9857","beginDate":"2004-02-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-22","modifiedBy":"REEVESD","dateModified":"2008-07-22","deletedIndicator":"No"},{"value":"3","valueDescription":"Stage 3: Diarrhea > 1500 mL","ValueMeaning":{"publicId":"2768293","version":"1","preferredName":"Stage 3: Diarrhea > 1500 mL","longName":"2768293","preferredDefinition":"Stage 3: Diarrhea > 1500 mL in acute GVHD","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"52A62BCD-3BE3-610A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"52A62BCD-3BFC-610A-E044-0003BA3F9857","beginDate":"2004-02-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-22","modifiedBy":"REEVESD","dateModified":"2008-07-22","deletedIndicator":"No"},{"value":"4","valueDescription":"Stage 4: Severe abdominal pain or ileus","ValueMeaning":{"publicId":"2768294","version":"1","preferredName":"Stage 4: Severe abdominal pain or ileus","longName":"2768294","preferredDefinition":"Stage 4: Severe abdominal pain or ileus in acute GVHD","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"52A62BCD-3C08-610A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"52A62BCD-3C21-610A-E044-0003BA3F9857","beginDate":"2004-02-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-22","modifiedBy":"REEVESD","dateModified":"2008-07-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2768289","version":"1","preferredName":"Glucksberg Scale Gastrointestinal Stage","preferredDefinition":"The Glucksberg scale is a severity index for grading acute graft-versus-host disease (GVHD) after allogeneic marrow transplantation. This index is based on the results of an analysis in which distinct patterns in the peak severity of GVHD involvement in the skin, liver, and gut were correlated with the risks of transplant-related mortality (TRM) and treatment failure (defined as relapse or death).:(GAS-tro-in-TES-tih-nul) GI.  Refers to the stomach and intestines.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C42297:C13359:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glucksberg Scale","conceptCode":"C42297","definition":"The Glucksberg scale is a severity index for grading acute graft-versus-host disease (GVHD) after allogeneic marrow transplantation. This index is based on the results of an analysis in which distinct patterns in the peak severity of GVHD involvement in the skin, liver, and gut were correlated with the risks of transplant-related mortality (TRM) and treatment failure (defined as relapse or death).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Gastrointestinal","conceptCode":"C13359","definition":"Pertaining to the stomach and intestines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"52A60E35-D8C5-580E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-22","modifiedBy":"ONEDATA","dateModified":"2008-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"52A60E35-D8D6-580E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-22","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[{"name":"ENGLISH","type":"CONTEXT NAME","context":"CCR"}],"ReferenceDocuments":[{"name":"GI Stage","type":"Preferred Question Text","description":"GI Stage","url":null,"context":"CCR"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D2F0AC9A-5117-3D8A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-12","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-02-12","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}